Articles Archives - Page 487 of 733

ThursdayOct 22, 2020 9:23 am

InsuraGuest Technologies, Inc. (TSX.V: ISGI) Proprietors Policy Portal Now Open for Business

Launch of InsurTech Portal to Offer Business Owner Liability Protection The Insure the People Portal to Provide Coverage to Over 130 Class Codes Coverage for Building & Business Property and Business Income General Liability Occurrence Limits: US$300,000, US$500,000, US$1 million and US$2 million Employment Practices Liability With the launch of its business owner policy (“BOP”) portal, InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTC: IGSTF) is extending its general liability coverage to a vital sector of the U.S. economy: small businesses. Through the site—InsureThePeople.com—small business owners and operators of a wide range of enterprises, from public accountants to commodity merchants to bars…

WednesdayOct 21, 2020 1:05 pm

Mushrooms’ Potential in Functional Foods Market Being Realized by Therapeutics Innovator Rritual Mushrooms

Emerging Wellness Foods Brand Rritual Mushrooms Inc. is developing plant-based superfood products to lead out a fledgling market segment that has a high degree of promise as consumer interest in functional foods increases While the mushroom therapeutics subcategory of products is still new and developing, analysts researching the overall functional foods market expect the industry to grow at a CAGR of 7.9 percent to $275.77 billion between 2019 and 2025 Rritual Mushrooms’ introductory product line draws on the reputations of the Chaga, Lion’s Mane and Reishi mushrooms as beneficial to overall wellness, combining them with herbal remedy adaptogens in powdered…

WednesdayOct 21, 2020 9:27 am

Predictive Oncology Inc. (NASDAQ: POAI) Industry Leader in Growing Precision Medicine Market

Recent study reports CAGR of 9.7% in precision medicine space. Predictive Oncology focused on use of data, artificial intelligence to develop personalized cancer therapies. One of POAI’s primary projects is building multi-omic predictive models of tumor drug response A recent study of the global precision medicine market indicates a bright future for the industry, especially for U.S.-based companies focusing on cancer research, such as Predictive Oncology Inc. (NASDAQ: POAI). The study reported a CAGR of 9.7% in the sector, with North America dominating the market and oncology expected to hold the highest market. “Precision medicine, a combination of molecular biology…

TuesdayOct 20, 2020 11:46 am

Gage Cannabis Co. Announces Pre-IPO Financing Round, Early Opportunity to Invest in Top Operator

Round of financing led by Bruce Linton, executive chairman of Gage Cannabis and cannabis industry pioneer Reg A+ equity financing offers chance to invest in exclusive cultivator, processor, and retailer of world-leading cannabis brands First step in Gage’s journey to becoming publicly traded company Gage Cannabis Co., the leading high-quality craft cannabis brand and operator in Michigan, has launched a Regulation A, Tier 2, equity financing. The pre-IPO round of financing is being led by Bruce Linton, executive chairman of Gage Cannabis, a founder and former CEO and chairman of Canopy Growth Corp. “We wanted to provide investors with the…

MondayOct 19, 2020 11:33 am

Pac Roots Cannabis Corp. (PACR) Set to Benefit as Hemp and Cannabis Producers Evolve, Differentiate Crop Cultivation

Pac Roots Cannabis Corp. specializes in creation of unique, proprietary cannabis and hemp strains Following its tie-up with Phenome One Corp, Pac Roots offers over 350 meticulously designed cultivars possessing wide array of characteristics Introduction of patent protection on genetically modified hemp strains along with insurance provided to hemp growers incentivizes hemp production, drives greater demand for genetically modified seeds and cultivars Since completing its RTO and being listed on the CSE in May of 2020, Pac Roots Cannabis (CSE: PACR) has earned a reputation for operating on the cutting edge of hemp and cannabis cultivation. This foresight in staying…

MondayOct 19, 2020 10:56 am

SRAX Inc. (NASDAQ: SRAX) Spinoff BIGtoken(R) Inc. Announces George Stella as Chief Revenue Officer

George Stella appointed chief revenue officer of BIGtoken following executive vice president tenure at SRAX SRAX moving BIGtoken to separate publicly traded company through definitive share exchange agreement with Force Protection Video Equipment Corp BIGtoken platform compensates over 16 million users for data that marketers access for fee BIGtoken(R) Inc., a former SRAX (NASDAQ: SRAX) division, has appointed SRAX executive vice president George Stella as chief revenue officer of BIGtoken following its transition to a publicly-traded company. BIGtoken is a consumer data management and distribution system empowering brands to unlock the power of data through a transparent platform that rewards…

FridayOct 16, 2020 10:57 am

180 Life Sciences Corp. Expands IP Portfolio with EU, U.S., and Chinese Patents

The company’s patent portfolio includes its own intellectual property and exclusive worldwide licenses, including in the U.S., Canada, Europe, Australia, Hong Kong, and China 180 Life Sciences is in the final stages of its merger process with KBL Merger Corp. IV, with the resulting entity to list on NASDAQ under the ticker “ATNF” The company is devoting its clinical-stage biotechnology research to producing solutions that will help battle inflammation. Its primary focus is to treat fibrosis and inflammation using anti-TNF therapy The estimated annual market size for anti-inflammatory therapeutics is projected to grow to an estimated $106.1 billion in 2020.…

FridayOct 16, 2020 10:19 am

Rritual Mushrooms Inc. Takes Aim at New Wellness Industry in Functional Foods Marketplace

Rritual Mushrooms Inc. is an emerging producer of premium plant-based superfood products designed to help people meet the demands of modern life with style and ease The company introduced the wellness and nutraceuticals market to its suite of three mushroom and adaptogen-based elixir powders in September Rritual Mushrooms’ products were created to boost immunity, support brain function and help the body fight anxiety Rritual is positioned to take advantage of lifestyle trends that have promoted plant-based proteins and reduced meat consumption in recent years, as well as an invigorated interest in immunity-enhancing substances brought on by the worldwide COVID-19 pandemic…

ThursdayOct 15, 2020 1:13 pm

Net Element Inc. (NASDAQ: NETE) Well-Poised to Capitalize as EV Market Set to Grow by 29% per Annum Over Next Decade

Net Element’s reverse merger with EV manufacturer Mullen Technologies expected to close by 4Q2020 Mullen expects to begin marketing Dragonfly K50, sold in conjunction with JV partner Qiantu Motors from 2Q2021 followed by its own EV SUV in 2022 Deloitte expects annual EV sales to rise from 2.5mn in 2020 to 31.1mn in 2030, implying 29% CAGR over next ten years By 2030, EVs expected to account for 32% of all automobile sales globally, approximately 27% in United States Net Element (NASDAQ: NETE), a financial technology company which has recently transformed its business model to become a pure-play electric vehicle…

ThursdayOct 15, 2020 12:23 pm

AzurRx BioPharma Inc. (NASDAQ: AZRX) is “One to Watch”

AzurRx BioPharma’s lead therapeutic, MS1819, is a recombinant lipase treatment for exocrine pancreatic insufficiency and is currently targeting patients with cystic fibrosis and chronic pancreatitis – an established global market of more than $2 billion The company is currently pursuing parallel monotherapy and combination therapy trials, which are anticipated to produce topline data in Q1 2021 and Q2 2021, respectively Previously completed clinical trials of MS1819 showed primary and secondary endpoint efficacy, with a positive safety profile To fully finance its ongoing Phase 2 trials and being preparations for a pivotal Phase 3 study in 2021, as well as to…

Site Search

Company Search

Category: Articles